These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 32297650)

  • 1. Late onset obsessive-compulsive disorder (OCD): A case report.
    Lozano-Vicario L; Fernández-Sotos P; Lozoya-Moreno S; Del Yerro-Álvarez MJ
    Actas Esp Psiquiatr; 2020 Jan; 48(1):36-46. PubMed ID: 32297650
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative, single-blind, randomized study on quetiapine and aripiperazole augmentation in treatment of selective serotonin reuptake inhibitor refractory obsessive-compulsive disorder.
    Talaei A; Hosseini FF; Aghili Z; Akhondzadeh S; Asadpour E; Mehramiz NJ; Forouzanfar F
    Can J Physiol Pharmacol; 2020 Apr; 98(4):236-242. PubMed ID: 32228235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parental obsessive-compulsive disorder as a prognostic factor in a year long fluvoxamine treatment in childhood and adolescent obsessive-compulsive disorder.
    Yaryura-Tobias JA; Grunes MS; Walz J; Neziroglu F
    Int Clin Psychopharmacol; 2000 May; 15(3):163-8. PubMed ID: 10870874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.
    McDougle CJ; Goodman WK; Leckman JF; Lee NC; Heninger GR; Price LH
    Arch Gen Psychiatry; 1994 Apr; 51(4):302-8. PubMed ID: 8161290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment-resistant self-mutilation, tics, and obsessive-compulsive disorder in neuroacanthocytosis: a mouth guard as a therapeutic approach.
    Fontenelle LF; Leite MA
    J Clin Psychiatry; 2008 Jul; 69(7):1186-7. PubMed ID: 18687019
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery.
    Mukai Y; Two A; Jean-Baptiste M
    BMJ Case Rep; 2011 Aug; 2011():. PubMed ID: 22687661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The psychopharmacological treatment of obsessive-compulsive disorder: a review.
    Insel TR; Murphy DL
    J Clin Psychopharmacol; 1981 Sep; 1(5):304-11. PubMed ID: 6174553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Dose Quetiapine Fumarate (50 mg) for Obsessive-Compulsive Disorder Patients With Comorbid Bipolar Depression.
    Poyurovsky M; Weizman A
    Clin Neuropharmacol; 2021 Sep-Oct 01; 44(5):196-197. PubMed ID: 34456228
    [No Abstract]   [Full Text] [Related]  

  • 9. Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
    Mundo E; Maina G; Uslenghi C
    Int Clin Psychopharmacol; 2000 Mar; 15(2):69-76. PubMed ID: 10759337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
    Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvoxamine approved for treating OCD in children.
    J Psychosoc Nurs Ment Health Serv; 2001 Jan; 39(1):11. PubMed ID: 11197991
    [No Abstract]   [Full Text] [Related]  

  • 12. Compulsive exhibitionism successfully treated with fluvoxamine: a controlled case study.
    Zohar J; Kaplan Z; Benjamin J
    J Clin Psychiatry; 1994 Mar; 55(3):86-8. PubMed ID: 8071253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvoxamine: a review of its therapeutic potential in the management of anxiety disorders in children and adolescents.
    Cheer SM; Figgitt DP
    Paediatr Drugs; 2001; 3(10):763-81. PubMed ID: 11706925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open study of fluvoxamine augmentation of neuroleptics in schizophrenia with obsessive and compulsive symptoms.
    Reznik I; Sirota P
    Clin Neuropharmacol; 2000; 23(3):157-60. PubMed ID: 10895399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder.
    McDougle CJ; Goodman WK; Leckman JF; Holzer JC; Barr LC; McCance-Katz E; Heninger GR; Price LH
    Am J Psychiatry; 1993 Apr; 150(4):647-9. PubMed ID: 8465885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder.
    Uguz F
    Gen Hosp Psychiatry; 2010; 32(5):556-8. PubMed ID: 20851277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
    Milanfranchi A; Ravagli S; Lensi P; Marazziti D; Cassano GB
    Int Clin Psychopharmacol; 1997 May; 12(3):131-6. PubMed ID: 9248868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of psychogenic excoriation and obsessive compulsive disorder using aripiprazole and fluoxetine.
    Curtis AR; Richards RW
    Ann Clin Psychiatry; 2007; 19(3):199-200. PubMed ID: 17729023
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment.
    Cavedini P; Erzegovesi S; Ronchi P; Bellodi L
    Eur Neuropsychopharmacol; 1997 Feb; 7(1):45-9. PubMed ID: 9088884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.